The global gabapentin market, valued at USD 2.11 billion in 2023, is poised for significant growth in the coming decade. Projections indicate a robust compound annual growth rate (CAGR) of 5.3%, with the market set to reach an impressive USD 3.54 billion by 2033. This surge in demand is largely attributed to the increasing prevalence …
Tag Archives: Gabapentin Market
Global Gabapentin Market Projected to Surge to USD 3.54 Billion by 2033
The global gabapentin market, valued at USD 2.11 billion in 2023, is set to experience substantial growth, reaching an estimated USD 3.54 billion by 2033, according to a recent market study. The market is anticipated to grow at a robust compound annual growth rate (CAGR) of 5.3% over the next decade. This significant market expansion …
Continue reading “Global Gabapentin Market Projected to Surge to USD 3.54 Billion by 2033”
Global Gabapentin Market is projected to Reach USD 3.54 Billion by 2033
The global gabapentin market, valued at USD 2.11 billion in 2023, is projected to witness substantial growth, reaching USD 3.54 billion by 2033, according to a recent market study. The market is anticipated to grow at a compound annual growth rate (CAGR) of 5.3% over the next decade. The increasing prevalence of conditions treated with …
Continue reading “Global Gabapentin Market is projected to Reach USD 3.54 Billion by 2033”
Gabapentin Market is anticipated to reach US$ 3.54 Billion by 2033, driven by the mounting cases of neurological and chronic pain conditions | FMI
The Gabapentin Market is capturing a valuation of US$ 2.11 billion in 2023 and is predicted to reach US$ 3.54 billion by 2033. The market is registering a CAGR of 5.3% during the forecast period. The Gabapentin market has witnessed significant growth in recent years, driven by its expanding range of medical applications and increasing recognition as …
Growing Prevalence Of Neurological And Chronic Pain Conditions Fueling Demand For Gabapentin Market To US$ 3.54 Billion By 2033 | FMI
The Gabapentin Market is capturing a valuation of US$ 2.11 billion in 2023 and is predicted to reach US$ 3.54 billion by 2033. The market is registering a CAGR of 5.3% during the forecast period. The Gabapentin market has witnessed significant growth in recent years, driven by its expanding range of medical applications and increasing recognition as …